However, emerging data indicate that SARS-CoV-2 vaccination diversifies the CD4+ S-reactive T cell repertoire in patients with prior SARS-CoV-2 infection (29, 30) or vaccine breakthrough infection with omicron (31). This evidence concerns the gene CD4 and infection.